Your browser doesn't support javascript.
loading
Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae.
Juhász, Viktor; Hornyik, Tibor; Benák, Attila; Nagy, Norbert; Husti, Zoltán; Pap, Róbert; Sághy, László; Virág, László; Varró, András; Baczkó, István.
Afiliación
  • Juhász V; a Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • Hornyik T; a Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • Benák A; b 2nd Department of Internal Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary.
  • Nagy N; c MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary.
  • Husti Z; a Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • Pap R; b 2nd Department of Internal Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary.
  • Sághy L; b 2nd Department of Internal Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary.
  • Virág L; a Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • Varró A; a Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
  • Baczkó I; c MTA-SZTE Research Group of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary.
Can J Physiol Pharmacol ; 96(1): 18-25, 2018 Jan.
Article en En | MEDLINE | ID: mdl-28892643
ABSTRACT
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a major cause of morbidity and mortality. Traditional antiarrhythmic agents used for restoration of sinus rhythm have limited efficacy in long-term AF and they may possess ventricular proarrhythmic adverse effects, especially in patients with structural heart disease. The acetylcholine receptor-activated potassium channel (IK,ACh) represents an atrial selective target for future AF management. We investigated the effects of the IK,ACh blocker tertiapin-Q (TQ), a derivative of the honeybee toxin tertiapin, on chronic atrial tachypacing-induced AF in conscious dogs, without the influence of anesthetics that modulate a number of cardiac ion channels. Action potentials (APs) were recorded from right atrial trabeculae isolated from dogs with AF. TQ significantly and dose-dependently reduced AF incidence and AF episode duration, prolonged atrial effective refractory period, and prolonged AP duration. The reference drugs propafenone and dofetilide, both used in the clinical management of AF, exerted similar effects against AF in vivo. Dofetilide prolonged atrial AP duration, whereas propafenone increased atrial conduction time. TQ and propafenone did not affect the QT interval, whereas dofetilide prolonged the QT interval. Our results show that inhibition of IK,ACh may represent a novel, atrial-specific target for the management of AF in chronic AF.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrilación Atrial / Potenciales de Acción / Canales de Potasio / Receptores Colinérgicos / Estado de Conciencia / Bloqueadores de los Canales de Potasio / Remodelación Atrial / Atrios Cardíacos Límite: Animals Idioma: En Revista: Can J Physiol Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Hungria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fibrilación Atrial / Potenciales de Acción / Canales de Potasio / Receptores Colinérgicos / Estado de Conciencia / Bloqueadores de los Canales de Potasio / Remodelación Atrial / Atrios Cardíacos Límite: Animals Idioma: En Revista: Can J Physiol Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Hungria